Cargando…

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

OBJECTIVES: The interleukin-6 receptor (IL-6R) blocker tocilizumab (TCZ) reduces inflammatory disease activity in rheumatoid arthritis (RA) but elevates lipid concentrations in some patients. We aimed to characterise the impact of IL-6R inhibition on established and novel risk factors in active RA....

Descripción completa

Detalles Bibliográficos
Autores principales:	McInnes, Iain B, Thompson, Liz, Giles, Jon T, Bathon, Joan M, Salmon, Jane E, Beaulieu, Andre D, Codding, Christine E, Carlson, Timothy H, Delles, Christian, Lee, Janet S, Sattar, Naveed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Clinical and Epidemiological Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392313/ https://www.ncbi.nlm.nih.gov/pubmed/24368514 http://dx.doi.org/10.1136/annrheumdis-2013-204345

Ejemplares similares

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
por: Welsh, Paul, et al.
Publicado: (2016)

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016)

Interleukin-18: a therapeutic target in rheumatoid arthritis?
por: McInnes, Iain B, et al.
Publicado: (2005)

Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study
por: Della-Torre, Emanuel, et al.
Publicado: (2020)

Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
por: McCarey, David W, et al.
Publicado: (2005)

Use of surrogate outcomes in US FDA drug approvals, 2003–2012: a survey
por: Yu, Tsung, et al.
Publicado: (2015)

Clinical efficacy, radiographic and safety findings through 2 years of golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of the randomised, placebo-controlled GO-REVEAL study
por: Kavanaugh, Arthur, et al.
Publicado: (2013)

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2013)

Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants
por: Siebert, Stefan, et al.
Publicado: (2016)

Clinical efficacy, radiographic and safety findings through 5 years of subcutaneous golimumab treatment in patients with active psoriatic arthritis: results from a long-term extension of a randomised, placebo-controlled trial (the GO-REVEAL study)
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials
por: Kavanaugh, Arthur, et al.
Publicado: (2014)

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial
por: Ritchlin, Christopher, et al.
Publicado: (2014)

Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis
por: Giles, Jon T, et al.
Publicado: (2005)

Randomised controlled trial of mammographic screening in women from age 40: predicted mortality based on surrogate outcome measures
por: Moss, S, et al.
Publicado: (2005)

Left ventricular remodeling in rheumatoid arthritis patients without clinical heart failure
por: Park, Elizabeth, et al.
Publicado: (2023)

Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017)

Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank
por: Ferguson, Lyn D, et al.
Publicado: (2019)

Associations of maternal 25-hydroxyvitamin D in pregnancy with offspring cardiovascular risk factors in childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children
por: Williams, Dylan M, et al.
Publicado: (2013)

Associations of time of day with cardiovascular disease risk factors measured in older men: results from the British Regional Heart Study
por: Sartini, Claudio, et al.
Publicado: (2017)

Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancer
por: Lundgren, Christine, et al.
Publicado: (2019)

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
por: Fragoulis, George E, et al.
Publicado: (2019)

Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity – a cross-sectional study
por: Ferguson, Lyn D, et al.
Publicado: (2020)

Environmental factors associated with general practitioner consultations for allergic rhinitis in London, England: a retrospective time series analysis
por: Todkill, Dan, et al.
Publicado: (2020)

SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UK
por: Mackenzie, Ruth M, et al.
Publicado: (2021)

2091: Evaluating the validity and utility of surrogate endpoints in clinical trials of chronic kidney disease (CKD)
por: Ying, Jian, et al.
Publicado: (2018)

Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role?
por: Troisi, R, et al.
Publicado: (2007)

Association of maternal lipid levels with birth weight and cord blood insulin: a Bayesian network analysis
por: Wang, Jingya, et al.
Publicado: (2022)

Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
por: Sieper, Joachim, et al.
Publicado: (2014)

Cohort profile: development and characteristics of a retrospective cohort of individuals dispensed prescription opioids for non-cancer pain in British Columbia, Canada
por: Wilton, James, et al.
Publicado: (2021)

Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: results from a UK Biobank prospective cohort study
por: Ho, Frederick K, et al.
Publicado: (2020)

Predictors of exercise participation in ambulatory and non-ambulatory older people with multiple sclerosis
por: Ploughman, Michelle, et al.
Publicado: (2015)

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
por: Dougados, Maxime, et al.
Publicado: (2014)

Compensation of Physical Activity and Sedentary Time in Primary School Children
por: RIDGERS, NICOLA D., et al.
Publicado: (2014)

Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study
por: Pappas, Dimitrios A, et al.
Publicado: (2010)

Leukotrienes, mast cells, and T cells
por: McInnes, Iain B
Publicado: (2003)

Introduction
por: McInnes, Iain B
Publicado: (2003)

T Cell Maturation in Inflammatory Synovitis
por: McInnes, Iain B
Publicado: (2000)

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study
por: Schiff, Michael, et al.
Publicado: (2011)

Investigating the epidemiology of medication errors and error-related adverse drug events (ADEs) in primary care, ambulatory care and home settings: a systematic review protocol
por: Assiri, Ghadah Asaad, et al.
Publicado: (2016)

Association of Cross-Reactive Antibodies Targeting Peptidyl-Arginine Deiminase 3 and 4 with Rheumatoid Arthritis-Associated Interstitial Lung Disease
por: Giles, Jon T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_plf46kv9t0bdnm7ocnbmdq7hjd